https://seekingalpha.com/news/3829845-horizons-uplizna-gets-approval-in-eu-to-treat-nervous-system-disorder-of-eye-spine
The European Commission ((EC)) approved Horizon Therapeutics' (HZNP) Uplizna as a standalone therapy for adult patients with neuromyelitis optica spectrum disorder ((NMOSD)) who...
Create an account
or login to join the discussion